 |
 |
 |
|
||
|
 |
|
|
 |
|
Heart HealthHERS recommendationsThe National Heart, Lung, and Blood Institute (NHLBI) continues to advise postmenopausal women considering hormone replacement therapy--both those with and without CHD--to discuss this issue with their health care provider. The decision to continue or to stop HRT is complicated, and the benefits and risks of treatment should be decided on an individual basis. A woman's health profile and her family history of heart disease; uterine, breast, and ovarian cancers; and osteoporosis should be evaluated when considering HRT. Postmenopausal women should also discuss with their health care providers the many other options available for the prevention and treatment of CHD.
Source: The National Heart, Lung and Blood Institute
|
|
 Clinicians | Practices | All About Pregnancy | All About MidLife | Health & Wellness | Home  ©2001-2002 Women's Health USA, Inc. |